Home > Analytics > INDO US BIOTECH

INDO US BIOTECH
Intrinsic Value | Fundamental Analysis

BOM : 541304     NSE :     
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : Average
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : NA
May 28,2024
Price(EOD): ₹ 209.00
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Agriculture
MCap: ₹ 420.09 Cr
Value of ₹ 1 Lac invested in INDO US BIOTECH
on May 28,2019 (price: ₹ 40.42)

₹ 1 L

₹ 5.17 L

1W : -3.2% 1M : -9.1% 1Y : 106.5%
COMMUNITY POLL
for INDO US BIOTECH
Please provide your vote to see the results
Industry Peers & Returns1W1M1Y
INDO US BIOTECH -3.2% -9.1% 106.5%
BOMBAY BURMAH TRADING CORPORATION -2.2% -3.4% 63%
KAVERI SEED COMPANY -3.9% -3.4% 65.5%
VENKYS (INDIA) -0.7% 0.8% 13.4%
BOMBAY SUPER HYBRID SEEDS -0.8% -5.8% -30.6%
TIERRA AGROTECH 13.4% -11.8% -49.4%
NATH BIOGENES (INDIA) -2.6% -10.6% 13.3%
MANGALAM SEEDS -5.9% -12.5% 56.4%
SHREE OSWAL SEEDS AND CHEMICALS -2.5% -13% -53.7%

FUNDAMENTAL ANALYSIS OF INDO US BIOTECH

 
Fundamentals Score
[ Q(TTM): Mar2024, Y: Mar2023
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF INDO US BIOTECH

 
Valuation Score
[As on : May 28,2024 ]

Ratio Standalone
P/E
P/B
P/S
50.8
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 8.25 Cr
[Latest Qtr - Mar2024 - Standalone Results ]

6.68
P/B Calculated based on Book Value of Rs 62.75 Cr
[Latest Year - Mar2024 - Standalone Results ]

5.75
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Mar2024 - Standalone Results ]

Financial Ratios →

Insights 💡 There are potential 12% undervalued companies ! Discover More →

FAIR VALUE OF INDO US BIOTECH

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
322%
355%
296%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF INDO US BIOTECH



INDO US BIOTECH vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF INDO US BIOTECH

Year Debt/Equity ratio
Standalone Consolidated
2023
2022
2021
Avg_3yrs
0.21
0.32
0.53
0.35
-
0.33
0.54
0.29
[Last Annual Data : Mar2023]
Financial Ratios →

PLEDGED PROMOTER SHARES OF INDO US BIOTECH

Pledged Promoter Shares
NA

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF INDO US BIOTECH

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-28.71%
-77.12%
-83.24%
-85.78%
-12.94%
-68.65%
-76.15%
-81.1%
QtrlyTrend
-8
Latest Qtr: Mar2024
Quarterly Result Analysis →


INDO US BIOTECH related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about INDO US BIOTECH


Is INDO US BIOTECH good for long term investment?

As on May 28,2024, the Fundamentals of INDO US BIOTECH look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of INDO US BIOTECH . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is INDO US BIOTECH UnderValued or OverValued?

As on May 28,2024, INDO US BIOTECH is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of INDO US BIOTECH ?

As on May 28,2024, the Intrinsic Value of INDO US BIOTECH is Rs. 49.55 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 49.55
Fair Value [Median EV / Sales Model] : Rs. 45.91
Fair Value [Median Price / Sales Model] : Rs. 52.81
Estimated Median Fair Value of INDO US BIOTECH : Rs. 49.55

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is INDO US BIOTECH trading at a Premium or Discount?

As on May 28,2024, INDO US BIOTECH is trading at a Premium of 322% based on the estimates of Median Intrinsic Value!